Novel Agent First to Slow Disability in nrSPMS ...Middle East

The Bruton's tyrosine kinase inhibitor tolebrutinib is reportedly the first agent to show benefit in patients with nonrelapsing secondary progressive MS. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Novel Agent First to Slow Disability in nrSPMS )

Also on site :

• Morning Report — Texas braces for more flood danger after Hill Country tragedy 
• Bangladesh lawyers challenge ex-PM Hasina’s murder trial charges
• Ukraine plagued by ‘palace politics’ and purges – Economist